Preemptive Zepatier Treatment in Donor HCV Positive to Recipient HCV Negative Cardiac Transplant

Stopped moved forward with another protocol utilizing pan genotypic treatment once it became commercially available and FDA approved

Conditions

• Cardiac Transplant Disorder
• Hepatitis C

Interventions

• DRUG: Combindation treatment with Grazoprevir and Elbasvir fixed dose combination tablet, with or without ribavirin

Sponsor

Raymond T. Chung, MD

Collaborators

• [object Object]